Australians are making significant adjustments to their private health insurance arrangements as the pinch of rising living costs intensifies, coinciding with one of the most substantial government-sanctioned premium hikes in nearly a decade. This trend emerges against a backdrop of an Australian healthcare system grappling with ongoing strain and, in certain regions, exhibiting signs of faltering, according to the chief executive of the nation’s largest listed health insurer.
Medibank Private recently disclosed an 11 per cent decrease in its net profit after tax for the first half of the 2025/26 financial year, settling at $302.9 million. The underlying profit, which excludes certain non-health-related expenditures and impacts that tempered growth in its core operations, saw a marginal dip to $297.8 million, falling short of market expectations. This financial performance led to a 6.6 per cent decline in Medibank’s share price, closing at $4.50.
Despite the profit dip, the company experienced a robust increase in health insurance premium revenue, climbing by approximately four per cent to $4.1 billion. This revenue growth occurred even as the total claims processed by Medibank amounted to $3.4 billion. A notable positive for Medibank was the addition of 38,300 resident policyholders in the first half of the year. This represents a near doubling of the growth seen in the corresponding period of the previous financial year, bringing the total number of resident policyholders to around two million.
Navigating Cost-of-Living Pressures
David Koczkar, Medibank’s Chief Executive, acknowledged the financial pressures faced by many of its customers. “We are very conscious that many customers are doing it tough, including with the recent interest rate increase and recently announced increases to premiums,” he stated during an earnings call with analysts. He further elaborated that despite this challenging economic climate, the market for resident health insurance remains strong. This buoyancy is characterised by a sustained surge in younger Australians opting for private health cover. Koczkar anticipates that the growth rates for resident policyholders will continue to outpace pre-pandemic levels.
The impending rise in health insurance premiums, with Medibank announcing an average increase of 5.1 per cent effective from April, follows a broader industry-wide average premium rise of 4.41 per cent approved by the federal government for the current year. This industry-wide increase marks the most significant single-year jump in premiums since 2017. Medibank has indicated that its premium adjustment translates to an additional cost of approximately $2.14 per week for individuals with a single policy and $4.46 per week for families.
International Student Market Dynamics
In addition to its resident policyholders, Medibank observed a 0.4 per cent year-on-year increase in non-residential policies, primarily held by international students, reaching nearly 350,000 in the first half of the year. While this figure is slightly down from the end of the previous financial year, Medibank’s performance in this segment remains stronger than the overall market. “While we are seeing slightly lower policyholder growth rates in our non-resident business from a few years ago, our performance remains better than market,” Mr Koczkar commented.
The non-resident market has shown signs of adaptation following recent federal government migration reforms. The number of overseas students has stabilised, while the intake of foreign workers has seen an increase. “But we expect the market to continue to grow and we are also seeing more students and workers become residents,” Koczkar noted. He expressed confidence in Medibank’s continued appeal, stating, “We remain insurer of choice for the student market.”
The Allure of Private Cover Amidst Public System Strain
The enduring appeal of private health insurance is significantly influenced by the persistent challenges within Australia’s public hospital system, particularly the extended waiting periods for elective surgeries. Mr Koczkar highlighted that consumers are actively seeking better value by switching between health insurance brands and products. Furthermore, in response to soaring living costs, many are opting for lower levels of health cover.
Beyond the individual consumer choices, Koczkar painted a broader picture of concern regarding the Australian hospital and healthcare system. He asserted that despite substantial government investment, the system is experiencing difficulties in various areas. “Australia has never spent more on healthcare and yet, in some parts, the system is failing,” he remarked. Specific issues he raised include escalating out-of-pocket expenses for patients, longer waiting times for medical care, increased pressure on healthcare professionals, and a rate of avoidable hospitalisations that is approximately 30 per cent higher than the OECD average. Koczkar concluded by expressing that the pace of necessary hospital reforms is considerably too slow.
In terms of financial returns to shareholders, Medibank announced an interim dividend of 8.3 cents per share, representing a 6.4 per cent increase.
